SEK105.70
5.07% day before yesterday
Stockholm, Aug 22, 05:29 pm CET
ISIN
SE0014428512
Symbol
SUS

Surgical Science Sweden AB Stock price

SEK105.70
-42.70 28.77% 1M
-53.50 33.61% 6M
-50.20 32.20% YTD
-25.20 19.25% 1Y
-50.10 32.16% 3Y
+27.70 35.51% 5Y
+46.95 79.91% 10Y
+46.95 79.91% 20Y
Stockholm, Closing price Fri, Aug 22 2025
+5.10 5.07%
ISIN
SE0014428512
Symbol
SUS

Key metrics

Basic
Market capitalization
SEK5.1b
Enterprise Value
SEK4.5b
Net debt
positive
Cash
SEK612.9m
Shares outstanding
51.0m
Valuation (TTM | estimate)
P/E
38.2 | 27.3
P/S
5.4 | 4.5
EV/Sales
4.8 | 4.0
EV/FCF
80.8
P/B
1.2
Financial Health
Equity Ratio
88.1%
Return on Equity
2.7%
ROCE
3.1%
ROIC
-
Debt/Equity
0.0
Financials (TTM | estimate)
Revenue
SEK946.5m | SEK1.1b
EBITDA
SEK190.8m | SEK286.3m
EBIT
SEK142.3m | SEK226.2m
Net Income
SEK141.1m | SEK197.4m
Free Cash Flow
SEK56.0m
Growth (TTM | estimate)
Revenue
12.4% | 29.0%
EBITDA
- | 41.1%
EBIT
-12.1% | 56.8%
Net Income
-32.2% | 49.9%
Free Cash Flow
-64.7%
Margin (TTM | estimate)
Gross
68.4%
EBITDA
20.2% | 25.1%
EBIT
15.0%
Net
14.9% | 17.3%
Free Cash Flow
5.9%
More
EPS
SEK2.8
FCF per Share
SEK1.1
Short interest
-
Employees
274
Rev per Employee
SEK3.2m
Show more

Is Surgical Science Sweden AB a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,015 stocks worldwide.

Surgical Science Sweden AB Stock Analysis

Unlock Scores for Free

Analyst Opinions

9 Analysts have issued a Surgical Science Sweden AB forecast:

7x Buy
78%
2x Hold
22%

Analyst Opinions

9 Analysts have issued a Surgical Science Sweden AB forecast:

Buy
78%
Hold
22%

Financial data from Surgical Science Sweden AB

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
947 947
12% 12%
100%
- Direct Costs 299 299
13% 13%
32%
647 647
12% 12%
68%
- Selling and Administrative Expenses 261 261
12% 12%
28%
- Research and Development Expense 189 189
5% 5%
20%
191 191
-
20%
- Depreciation and Amortization 49 49
-
5%
EBIT (Operating Income) EBIT 142 142
12% 12%
15%
Net Profit 141 141
32% 32%
15%

In millions SEK.

Don't miss a Thing! We will send you all news about Surgical Science Sweden AB directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Surgical Science Sweden AB engages in the development of simulators for laparoscopic medical training. Its products include LapSim, offers a procedural simulation for cholecystectomy, appendectomy, advanced suturing and anastomosis, gynecology, hysterectomy, bariatrics, and nephrectomy; EndoSim, for endoscopy simulation; and TeamSim, for realistic training of collaboration within a surgery team. The company was founded by Anders Hyltander, David Löfstrand, and Anders Larsson on July 24, 1997 and is headquartered in Gothenburg, Sweden.

Head office Sweden
CEO Mr. Englund
Employees 274
Founded 1997
Website surgicalscience.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today